The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer.

Saved in:
Bibliographic Details
Title: The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer.
Authors: Garsed DW; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. dale.garsed@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia. dale.garsed@petermac.org., Pandey A; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Fereday S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Kennedy CJ; The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.; The University of Sydney, Sydney, New South Wales, Australia., Takahashi K; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan., Alsop K; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Hamilton PT; The Deeley Research Centre, BC Cancer, Victoria, British Columbia, Canada., Hendley J; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Chiew YE; The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.; The University of Sydney, Sydney, New South Wales, Australia., Traficante N; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Provan P; The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.; The University of Sydney, Sydney, New South Wales, Australia., Ariyaratne D; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Au-Yeung G; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Bateman NW; Women's Health Integrated Research Center, Gynecologic Cancer Center of Excellence, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA., Bowes L; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; The Royal Women's Hospital, Parkville, Victoria, Australia., Brand A; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.; The University of Sydney, Sydney, New South Wales, Australia., Christie EL; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Cunningham JM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Friedlander M; Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales, Australia., Grout B; Sydney, New South Wales, Australia., Harnett P; The University of Sydney, Sydney, New South Wales, Australia.; Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia., Hung J; The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia., McCauley B; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., McNally O; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; The Royal Women's Hospital, Parkville, Victoria, Australia.; Department of Obstetrics and Gynaecology, The University of Melbourne, Parkville, Victoria, Australia., Piskorz AM; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Saner FAM; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Obstetrics and Gynecology, Bern University Hospital and University of Bern, Bern, Switzerland., Vierkant RA; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Wang C; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Winham SJ; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Pharoah PDP; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Department of Oncology, University of Cambridge, Cambridge, UK., Brenton JD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.; Department of Oncology, University of Cambridge, Cambridge, UK., Conrads TP; Women's Health Integrated Research Center, Gynecologic Cancer Center of Excellence, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA.; Women's Health Integrated Research Center, Women's Service Line, Inova Health System, Falls Church, VA, USA., Maxwell GL; Women's Health Integrated Research Center, Gynecologic Cancer Center of Excellence, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA.; Women's Health Integrated Research Center, Women's Service Line, Inova Health System, Falls Church, VA, USA., Ramus SJ; School of Clinical Medicine, Faculty of Medicine and Health, University of NSW, Sydney, New South Wales, Australia.; Adult Cancer Program, Lowy Cancer Research Centre, University of NSW, Sydney, New South Wales, Australia., Pearce CL; Department of Epidemiology and Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA., Pike MC; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Nelson BH; The Deeley Research Centre, BC Cancer, Victoria, British Columbia, Canada.; Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada.; Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada., Goode EL; Division of Epidemology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., DeFazio A; The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.; The University of Sydney, Sydney, New South Wales, Australia.; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia., Bowtell DDL; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. david.bowtell@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia. david.bowtell@petermac.org.
Source: Nature genetics [Nat Genet] 2022 Dec; Vol. 54 (12), pp. 1853-1864. Date of Electronic Publication: 2022 Dec 01.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1546-1718
DOI:10.1038/s41588-022-01230-9